Norpregnenes

"Norpregnenes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Pregnenes with one double bond or more than three double bonds which have undergone ring contractions or are lacking carbon-18 or carbon-19..

Descriptor ID

D009652

MeSH Number(s)

D04.808.668.651.693

Concept/Terms

Norpregnenes

Below are MeSH descriptors whose meaning is more general than "Norpregnenes".

Chemicals and Drugs [D]
Polycyclic Compounds [D04]
Steroids [D04.808]
Norsteroids [D04.808.668]
Norpregnanes [D04.808.668.651]
Norpregnenes [D04.808.668.651.693]

Below are MeSH descriptors whose meaning is related to "Norpregnenes".

Below are MeSH descriptors whose meaning is more specific than "Norpregnenes".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Norpregnenes" by people in Harvard Catalyst Profiles by year, and whether "Norpregnenes" was a major or minor topic of these publication.

Bar chart showing 6 publications over 5 distinct years, with a maximum of 2 publications in 2008

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	1	0	1
1995	0	1	1
2004	1	0	1
2008	2	0	2
2015	1	0	1

Below are the most recent publications written about "Norpregnenes" by people in Profiles.

Menopausal hormone therapy treatment options and ovarian cancer risk: A Swedish prospective population-based matched-cohort study. Int J Cancer. 2020 07 01; 147(1):33-44.

View in: PubMed
Tibolone decreases Lipoprotein(a) levels in postmenopausal women: A systematic review and meta-analysis of 12 studies with 1009 patients. Atherosclerosis. 2015 Sep; 242(1):87-96.

View in: PubMed
Add-back therapy with GnRH analogues for uterine fibroids. Cochrane Database Syst Rev. 2015 Mar 20; (3):CD010854.

View in: PubMed
Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation Into Cancer and Nutrition. Am J Epidemiol. 2010 Dec 15; 172(12):1394-403.

View in: PubMed
Tibolone rapidly attenuates the GABAB response in hypothalamic neurones. J Neuroendocrinol. 2008 Dec; 20(12):1310-8.

View in: PubMed
Tibolone and the promise of ideal hormone-replacement therapy. N Engl J Med. 2008 Aug 14; 359(7):753-5.

View in: PubMed
By the way, doctor. What happened to tibolone--the estrogen alternative we heard about a while ago? Did it turn out not to be effective? Harv Womens Health Watch. 2004 Apr; 11(8):8.

View in: PubMed
Hormone replacement therapy and breast tissue density on mammography. Menopause. 2002 Mar-Apr; 9(2):82-3.

View in: PubMed
Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet. 1995 Dec 16; 346(8990):1589-93.

View in: PubMed
Carbohydrate metabolism studies after one year of using an oral contraceptive containing gestodene and ethinyl estradiol. Contraception. 1994 Feb; 49(2):125-30.

View in: PubMed

Related Networks

People

Explore

Similar Concepts

Top Journals

N Engl J Med
J Neuroendocrinol
Harv Womens Health Watch
Contraception
Atherosclerosis
Lancet
Int J Cancer
Drug Metab Dispos
Cochrane Database Syst Rev
Am J Epidemiol